Oral administration of prosultiamine improved the symptoms in patients with overactive bladder associated with HTLV-1-related myelopathy/tropical spastic paraparesis, and also reduced urinary biomarkers.
Oral administration of prosultiamine improved the symptoms in patients with overactive bladder associated with HTLV-1-related myelopathy/tropical spastic paraparesis, and also reduced urinary biomarkers.
复制标题
口服普沙硫胺可改善与 HTLV-1 相关的脊髓病/热带痉挛性截瘫相关的膀胱过度活动症患者的症状，并降低尿液生物标志物。
DOI：
--
复制
发表时间：
2014
期刊：
影响因子：
--
通讯作者：
Sakai H
中科院分区：
文献类型：
--
作者：
Matsuo T;Nakamura T;Miyata Y;Ohba K;Sakai H
